Compare NATURAL CAPS with UNJHA FORMUL - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATURAL CAPS vs UNJHA FORMUL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATURAL CAPS UNJHA FORMUL NATURAL CAPS/
UNJHA FORMUL
 
P/E (TTM) x 28.6 -148.7 - View Chart
P/BV x 3.7 2.6 143.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 NATURAL CAPS   UNJHA FORMUL
EQUITY SHARE DATA
    NATURAL CAPS
Mar-21
UNJHA FORMUL
Mar-21
NATURAL CAPS/
UNJHA FORMUL
5-Yr Chart
Click to enlarge
High Rs14010 1,364.5%   
Low Rs345 662.5%   
Sales per share (Unadj.) Rs127.622.2 574.4%  
Earnings per share (Unadj.) Rs11.10.2 4,779.3%  
Cash flow per share (Unadj.) Rs18.00.4 4,360.9%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs99.74.3 2,328.1%  
Shares outstanding (eoy) m6.234.48 139.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.70.3 196.5%   
Avg P/E ratio x7.933.5 23.5%  
P/CF ratio (eoy) x4.818.7 25.8%  
Price / Book Value ratio x0.91.8 48.5%  
Dividend payout %9.00-   
Avg Mkt Cap Rs m54435 1,569.6%   
No. of employees `000NANA-   
Total wages/salary Rs m704 1,873.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m795100 798.7%  
Other income Rs m72 336.4%   
Total revenues Rs m802102 788.9%   
Gross profit Rs m1331 9,482.9%  
Depreciation Rs m431 5,316.0%   
Interest Rs m52 316.3%   
Profit before tax Rs m921 8,802.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m220-   
Profit after tax Rs m691 6,646.2%  
Gross profit margin %16.71.4 1,188.7%  
Effective tax rate %24.50-   
Net profit margin %8.71.0 835.8%  
BALANCE SHEET DATA
Current assets Rs m41924 1,746.1%   
Current liabilities Rs m33916 2,106.2%   
Net working cap to sales %10.28.0 127.4%  
Current ratio x1.21.5 82.9%  
Inventory Days Days460 11,444,027.6%  
Debtors Days Days122,546,28935,751,103 342.8%  
Net fixed assets Rs m55111 4,897.9%   
Share capital Rs m6245 139.1%   
"Free" reserves Rs m559-26 -2,180.4%   
Net worth Rs m62119 3,237.5%   
Long term debt Rs m00-   
Total assets Rs m97035 2,752.2%  
Interest coverage x17.81.6 1,115.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.82.8 29.0%   
Return on assets %7.77.8 98.4%  
Return on equity %11.15.4 206.2%  
Return on capital %15.614.4 108.8%  
Exports to sales %17.00-   
Imports to sales %00-   
Exports (fob) Rs m135NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13531 441.3%   
Fx outflow Rs m620-   
Net fx Rs m7431 239.9%   
CASH FLOW
From Operations Rs m126-7 -1,791.7%  
From Investments Rs m-156-1 23,973.8%  
From Financial Activity Rs m28NA-  
Net Cashflow Rs m-2-8 30.2%  

Share Holding

Indian Promoters % 56.6 36.9 153.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.4 63.1 68.8%  
Shareholders   5,521 4,135 133.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATURAL CAPS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATURAL CAPS SHARE PRICE


Jan 21, 2022 (Close)

TRACK NATURAL CAPS

  • Track your investment in NATURAL CAPS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATURAL CAPS 8-QTR ANALYSIS

COMPARE NATURAL CAPS WITH

MARKET STATS